Gino Kenny (Dublin Mid West, People Before Profit Alliance) | Oireachtas source

I understand that the cost of making the drug available is estimated to be €4,000 to €5,000 per patient per annum. Is the Minister of State saying that the manufacturer is out-pricing the HSE or that the HSE does not believe it is getting value for money?

See this speech in context